OpGen Files to Sell Up to $11.5M of Common Stock | GenomeWeb

This article has been updated to include information from a second SEC filing, filed by OpGen on Sept. 14.

NEW YORK (GenomeWeb) – OpGen late Wednesday filed a prospectus with the US Securities and Exchange Commission to sell up to $25 million of its common stock through Cowen and Co. on the Nasdaq, with initial sales to be limited to $11.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.